← all works
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Canadian affiliationAn author listed a Canadian institution. This is the only route the usual frame has.
Abstract
No abstract. This is not a gap in this database — OpenAlex has none either. 23.3% of the frame is in this state, and the screen finds HALF as much metaresearch here, so the absence is a measured bias rather than a missing field.
The record
- Venue
- The Lancet Oncology
- Topic
- Glioma Diagnosis and Treatment
- Field
- Medicine
- Canadian institutions
- University of CalgaryOntario Institute for Cancer ResearchQueen's UniversityHôpital Notre-DameWestern UniversityUniversity of TorontoPrincess Margaret Cancer Centre
- Funders
- —
- Keywords
- MedicineTemozolomideRadiation therapyConcomitantInternal medicineHazard ratioClinical endpointOncologyAdjuvantCancerClinical trialSurgeryConfidence interval
- Has abstract in OpenAlex
- no